Quality Systems – Page 276

Ccit Failure during sterile filtration: risk assessment for sterility assurance

Ccit Failure during Sterile Filtration: A Comprehensive Investigation Framework CCIT (Container Closure Integrity Testing) failures during sterile filtration processes can create significant risks for sterility assurance, particularly in the pharmaceutical…

Edge Lifting during die-cutting: root cause mapping across materials and process

An In-Depth Investigation into Edge Lifting during Die-Cutting in Pharmaceutical Manufacturing Edge lifting during die-cutting is a common yet critical deviation in the pharmaceutical manufacturing of transdermal drug delivery systems.…

Cleaning Validation Failure during method transfer: cleaning validation and worst-case selection

Investigation of Cleaning Validation Failures during Method Transfer: Practical Approaches In the realm of pharmaceutical manufacturing, cleaning validation is a critical component to ensure compliance with Good Manufacturing Practices (GMP).…

Edge Lifting at accelerated stability: GMP investigation plan and CAPA

Investigating Edge Lifting in Transdermal Drug Delivery Systems Under Accelerated Stability Edge lifting presents a significant challenge in the realm of transdermal drug delivery systems, particularly during accelerated stability testing.…

Phase Separation in cream manufacturing: GMP investigation and CAPA strategy

GMP Investigation and CAPA Strategy for Phase Separation in Cream Manufacturing Phase separation in cream manufacturing is a critical quality issue that can significantly impact product efficacy and safety. This…

Adhesion Failure during lamination: process parameter review and validation impact

Reviewing Process Parameters and Validation Impacts for Adhesion Failure during Lamination In the realm of pharmaceutical manufacturing, particularly in the production of transdermal drug delivery systems, adhesion failure during lamination…

Ph Drift in eye drop manufacturing: packaging integrity and CCIT justification

Investigating pH Drift Issues in Eye Drop Manufacturing: Ensuring Packaging Integrity and CCIT Justification pH drift during eye drop manufacturing presents a significant concern that can compromise product quality and…

Tube Leakage Complaint in cream manufacturing: packaging compatibility and stability justification

Addressing Tube Leakage Issues in Cream Manufacturing: An Investigation Approach Tube leakage complaints in cream manufacturing can significantly impact product quality, patient satisfaction, and regulatory compliance. When a packaging component…

Edge Lifting during lamination: process parameter review and validation impact

Reviewing Process Parameters and Validation Impact for Edge Lifting in Lamination In the complex realm of pharmaceutical manufacturing, edge lifting during lamination poses significant risks to product integrity and quality.…

Assay Oos during bulk hold: packaging compatibility and stability justification

Addressing Assay Out-of-Specification Results During Bulk Hold: A Comprehensive Investigation Approach Out-of-Specification (OOS) results for assays, particularly during bulk hold phases, can pose significant challenges in pharmaceutical manufacturing. Such occurrences…

Dropper Compatibility Failure during aseptic filling: FDA-ready investigation report and batch disposition

Investigating Dropper Compatibility Failures in Aseptic Filling: A Comprehensive Approach Dropper compatibility failures during aseptic filling can pose significant risks within pharmaceutical manufacturing environments, notably in the production of ophthalmic…

Ph Drift during method transfer: complaint trending and risk-based actions

Investigation of pH Drift During Method Transfer: Addressing Complaints and Implementing Risk-Based Actions pH drift during method transfer can significantly impact the quality and efficacy of pharmaceutical products, particularly in…